Therapeutic Targeting of the Cyclin D3:cdk4/6 Complex in T Cell Leukemia

Cancer Cell - United States
doi 10.1016/j.ccr.2012.09.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting CDK4/6 in Patients With Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2016English

Targeting IRAK1 in T-Cell Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2015English

Cyclin D3/CDK11p58 Complex Is Involved in the Repression of Androgen Receptor

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2007English

Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Targeting HTLV-I Latency in Adult T-Cell Leukemia/Lymphoma

Retrovirology
VirologyInfectious Diseases
2011English

CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Targeting FoxM1 Transcription Factor in T-Cell Acute Lymphoblastic Leukemia Cell Line

Leukemia Research
Cancer ResearchOncologyHematology
2015English

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2012English

CDK4/6 Inhibition in Cancer: The Cell Cycle Splicing Connection

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy